Quantitative beta-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes. Sakaki K, Murakami T, Yoshida H, Otani D, et al. Diabetes 2026 Mar 12:db251127. doi: 10.2337/db25-1127.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sakaki K, Murakami T, Yoshida H, Otani D, et al. Quantitative beta-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes. Diabetes 2026 Mar 12:db251127. doi: 10.2337/db25-1127.
PMID: 41814494